Neurology. 2008 Dec 9;71(24 Suppl 3):S21-3.

Tolerability, adherence, and patient outcomes.

Source

Department of Neurosciences, Loyola University Chicago, Stritch School of Medicine, 2160 S. First Ave., Maywood, IL 60153, USA. aperrin@lumc.edu

Abstract

Providing optimal patient care in multiple sclerosis (MS) is dependent on both the patient and the healthcare system. One of the greatest challenges to optimal patient care is ensuring patient adherence to treatment. The two reasons given most often for treatment discontinuation are adverse effects and lack of efficacy. Adverse effects can be anticipated and managed, in part through well-established protocols, but also through industry-sponsored nursing support programs. These strategies can reduce needless discontinuations when patients experience common adverse effects. Lack of efficacy can be addressed for many patients by providing them with enough education to develop reasonable expectations for treatment and long-term prognosis. As important as early and continuous treatment are, these strategies are essential for providing optimal patient care in MS.

PMID:: 19064871; [PubMed - indexed for MEDLINE]

MeSH Terms, Substances

MeSH Terms

Substances

Interferon-beta

LinkOut - more resources

Full Text Sources

Other Literature Sources

Labome Researcher Resource - ExactAntigen/Labome

Medical

Multiple Sclerosis - MedlinePlus Health Information

Supplemental Content

Save items

Related citations in PubMed

Treatment adherence and patient retention in the first year of a Phase-III clinical trial for the treatment of multiple sclerosis. [Mult Scler. 1999]
Treatment adherence and patient retention in the first year of a Phase-III clinical trial for the treatment of multiple sclerosis.
Mohr DC, Goodkin DE, Masuoka L, Dick LP, Russo D, Eckhardt J, Boudewyn AC, Bedell L. Mult Scler. 1999 Jun; 5(3):192-7.
Therapeutic expectations of patients with multiple sclerosis upon initiating interferon beta-1b: relationship to adherence to treatment. [Mult Scler. 1996]
Therapeutic expectations of patients with multiple sclerosis upon initiating interferon beta-1b: relationship to adherence to treatment.
Mohr DC, Goodkin DE, Likosky W, Gatto N, Neilley LK, Griffin C, Stiebling B. Mult Scler. 1996 Dec; 2(5):222-6.
Review Clinical effects and tolerability of high-dose, high-frequency recombinant interferon beta-1a in patients with multiple sclerosis: maximizing therapy through long-term adherence. [Expert Opin Biol Ther. 2010]
Review Clinical effects and tolerability of high-dose, high-frequency recombinant interferon beta-1a in patients with multiple sclerosis: maximizing therapy through long-term adherence.
Boyko AN. Expert Opin Biol Ther. 2010 Apr; 10(4):653-66.
Review Management strategies for improving the tolerability of interferons in the treatment of multiple sclerosis. [Can J Neurosci Nurs. 2008]
Review Management strategies for improving the tolerability of interferons in the treatment of multiple sclerosis.
Girouard N, Théorêt G. Can J Neurosci Nurs. 2008; 30(4):18-25.
Review [A wide support of patients with multiple sclerosis promotes success of long-term therapy]. [Zh Nevrol Psikhiatr Im S S Kor...]
Review [A wide support of patients with multiple sclerosis promotes success of long-term therapy].
Sidorenko TV, Khachanova NV, Boĭko AN. Zh Nevrol Psikhiatr Im S S Korsakova. 2006; Spec No 3:96-100.

See reviews... See all...

Cited by 1 PubMed Central article

When to initiate disease-modifying drugs for relapsing remitting multiple sclerosis in adults? [Mult Scler Int. 2011]
When to initiate disease-modifying drugs for relapsing remitting multiple sclerosis in adults?
Alkhawajah M, Oger J. Mult Scler Int. 2011; 2011:724871. Epub 2011 May 17.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Tolerability, adherence, and patient outcomes.
Tolerability, adherence, and patient outcomes.
Neurology. 2008 Dec 9 ;71(24 Suppl 3):S21-3.

PubMed
Early and long-term outcomes of heart failure in elderly persons, 2001-2005.
Early and long-term outcomes of heart failure in elderly persons, 2001-2005.
Arch Intern Med. 2008 Dec 8 ;168(22):2481-8.

PubMed
Effect of electronic prescribing with formulary decision support on medication u...
Effect of electronic prescribing with formulary decision support on medication use and cost.
Arch Intern Med. 2008 Dec 8 ;168(22):2433-9.

PubMed
Comparative effectiveness of beta-blockers in elderly patients with heart failur...
Comparative effectiveness of beta-blockers in elderly patients with heart failure.
Arch Intern Med. 2008 Dec 8 ;168(22):2422-8; discussion 2428-32.

PubMed
Inflammation and the emerging role of the toll-like receptor system in acute bra...
Inflammation and the emerging role of the toll-like receptor system in acute brain ischemia.
Stroke. 2009 Mar ;40(3 Suppl):S34-7. Epub 2008 Dec 8 .

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: